From 13 September 2021, the TER on this fund will be reduced to 0.18%. Please refer to the shareholder notice issued on 6 September 2021.


SPDR® MSCI Europe Health Care UCITS ETF STW FP

Important Risk Disclosure

Equity securities may fluctuate in value in response to the activities of individual companies and general market and economic conditions.

ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.

Investing in foreign domiciled securities may involve risk of capital loss from unfavorable fluctuation in currency values, withholding taxes, from differences in generally accepted accounting principles or from economic or political instability in other nations.

NAV EUR (Official NAV)

€182,36

as of 15 Oct 2021

Base Fund Currency

EUR

1 Day Nav Change

+€0,94 (+0,52%)

as of 15 Oct 2021

Assets Under Management

€658,59 M

as of 15 Oct 2021

TER

0,18%

image load fail

as of 31 Aug 2021


Fund Objective

Fund Objective

The investment objective of the Fund is to track the performance of European large and mid-sized companies in the Health Care sector.


Index Description

Index Description

The MSCI Europe Health Care 35/20 Capped Index is a free float-adjusted market capitalization weighted index that is designed to measure the equity market performance of constituents classified as Health Care (according to the Global Industry Classification Standard) in the MSCI Europe index.


Fund Information as of 18 Oct 2021

Fund Information as of 18 Oct 2021
ISIN iNAV Ticker

*These ticker codes are representative of the primary listing exchange.

Inception Date Countries of Registration Base Fund Currency Income Treatment Settlement Cycle
IE00BKWQ0H23 INSTW 05 Dec 2014 Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom EUR Accumulation Redemption Settlement Cycle, DD+2; Subscription Settlement Cycle, DD+2
ISIN IE00BKWQ0H23
iNAV Ticker

*These ticker codes are representative of the primary listing exchange.

INSTW
Inception Date 05 Dec 2014
Countries of Registration Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
Base Fund Currency EUR
Income Treatment Accumulation
Settlement Cycle Redemption Settlement Cycle, DD+2; Subscription Settlement Cycle, DD+2
Trading Cycle TER Benchmark Minimum Investment Trading Currency UCITS Compliant Domicile
DD 0,18% MSCI Europe Health Care 35/20 Capped Index 1 Share EUR, CHF, MXN Yes Ireland
Trading Cycle DD
TER 0,18%
Benchmark MSCI Europe Health Care 35/20 Capped Index
Minimum Investment 1 Share
Trading Currency EUR, CHF, MXN
UCITS Compliant Yes
Domicile Ireland
Investment Manager Sub-Investment Manager Fund Umbrella Replication Method Distribution Frequency PEA Eligible ISA Eligible
State Street Global Advisors Europe Limited State Street Global Advisors Limited SSGA SPDR ETFs Europe II plc Replicated - No Yes
Investment Manager State Street Global Advisors Europe Limited
Sub-Investment Manager State Street Global Advisors Limited
Fund Umbrella SSGA SPDR ETFs Europe II plc
Replication Method Replicated
Distribution Frequency -
PEA Eligible No
ISA Eligible Yes
SIPP Eligible UK Reporting Status Securities Lending
Yes Yes Yes
SIPP Eligible Yes
UK Reporting Status Yes
Securities Lending Yes

Listing and Ticker Information as of 18 Oct 2021

Listing and Ticker Information as of 18 Oct 2021

Exchange Trading Currency Listing Date Exchange Ticker SEDOL Code Bloomberg Code Reuters Code
Euronext Paris (Primary) EUR 08 Dec 2014 STW BM67JF6 STW FP STW.PA
SIX Swiss Exchange CHF 09 Dec 2014 STWX BM67JH8 STWX SE STWX.S
Deutsche Börse EUR 09 Dec 2014 SPYH BKX4075 SPYH GY SPYH.DE
London Stock Exchange EUR 09 Dec 2014 HLTH BSBNC41 HLTH LN HLTH.L
Borsa Italiana EUR 10 Dec 2014 STWX BM67JG7 STWX IM STWX.MI
Bolsa Mexicana de Valores MXN 12 Feb 2019 HLTHN BJCWGN1 HLTHN MM HLTHN.MX

INAV

INAV

Estimated NAV per Unit at 4PM, Hong Kong as of Estimated NAV per Unit as of (Updated every 15 seconds)
As of (Updated every 15 seconds)
INAV TICKER CURRENCY INAV
Estimated NAV per Unit at 4PM, Hong Kong as of
Estimated NAV per Unit as of (Updated every 15 seconds)
As of (Updated every 15 seconds)
INAV TICKER
CURRENCY
INAV

The Indicative NAV per share should not be viewed as the actual NAV per share. The Indicative NAV per share is provided for reference purposes only and may differ from the actual NAV per share calculated in accordance with the Prospectus.


Fund Characteristics as of 15 Oct 2021

Fund Characteristics as of 15 Oct 2021
Average Market Cap (M) Number of Holdings Average Price/Book Price/Earnings Ratio FY1
€114 849,42 M 40 4,40 19,02
Average Market Cap (M) €114 849,42 M
Number of Holdings 40
Average Price/Book 4,40
Price/Earnings Ratio FY1 19,02

Index Characteristics as of 15 Oct 2021

Index Characteristics as of 15 Oct 2021
Index Dividend Yield

This measures the weighted average of gross dividend Yield of stocks, in the index.

2,42%
Index Dividend Yield

This measures the weighted average of gross dividend Yield of stocks, in the index.

2,42%

Fund Market Price as of 15 Oct 2021

Fund Market Price as of 15 Oct 2021
Bid Price Offer Price Closing Price Bid/Offer Spread Day High Day Low 52 Week High
€132,20 €182,60 €182,52 €50,40 €182,52 €181,66 €191,18
Bid Price €132,20
Offer Price €182,60
Closing Price €182,52
Bid/Offer Spread €50,40
Day High €182,52
Day Low €181,66
52 Week High €191,18
52 Week Low
€146,38
52 Week Low €146,38

Fund Net Asset Value as of 15 Oct 2021

Fund Net Asset Value as of 15 Oct 2021
NAV EUR (Official NAV) NAV CHF NAV GBP NAV MXN Assets Under Management Shares in Issue
€182,36 CHF 195,33 £153,71 MXN $4 329,46 €658,59 M 3 611 500
NAV EUR (Official NAV) €182,36
NAV CHF CHF 195,33
NAV GBP £153,71
NAV MXN MXN $4 329,46
Assets Under Management €658,59 M
Shares in Issue 3 611 500
Most Recent NAV/NAV History

Reference NAVs are calculated for information purposes only. No warranty is provided as to the accuracy of reference NAVs. Reference NAVs are calculated with WM1600 FX (London time) rate applied in the currency indicated.


Fund Performance

Fund Performance

  • Fund Inception Date: 05 Dec 2014
  • Index Inception Date: 07 May 2020
  • Performance Inception Date: 30 Sep 2001

as of 30 Sep 2021

As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year Since Inception
30 Sep 2001
Fund Net 30 Sep 2021 -4,24% 1,55% 15,23% 12,78% 38,75% 51,45% 214,14%
Difference 30 Sep 2021 -0,01% -0,06% -0,04% -0,12% -0,52% -0,93% -16,78%
Fund Gross 30 Sep 2021 -4,22% 1,61% 15,44% 13,07% 39,94% 53,67% 239,29%
Difference 30 Sep 2021 0,00% 0,00% 0,17% 0,17% 0,67% 1,29% 8,37%
Index
MSCI Europe Health Care 35/20 Capped Index
30 Sep 2021 -4,23% 1,61% 15,27% 12,90% 39,27% 52,38% 230,92%

as of 30 Sep 2021

As Of 1 Month 3 Month YTD 1 Year 3 Year 5 Year Since Inception
30 Sep 2001
Fund Net 30 Sep 2021 -4,24% 1,55% 15,23% 12,78% 11,53% 8,66% 5,89%
Difference 30 Sep 2021 -0,01% -0,06% -0,04% -0,12% -0,14% -0,13% -0,28%
Fund Gross 30 Sep 2021 -4,22% 1,61% 15,44% 13,07% 11,85% 8,97% 6,30%
Difference 30 Sep 2021 0,00% 0,00% 0,17% 0,17% 0,18% 0,18% 0,13%
Index
MSCI Europe Health Care 35/20 Capped Index
30 Sep 2021 -4,23% 1,61% 15,27% 12,90% 11,67% 8,79% 6,17%

as of 30 Sep 2021

2021 (YTD) 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
Fund Net 15,23% -2,05% 31,62% -0,70% 2,75% -9,49% 14,77% 19,11% 25,31% 17,69% 13,64%
Difference -0,04% -0,15% -0,15% -0,12% -0,12% -0,11% -0,26% -0,17% -0,29% -0,19% -0,12%
Fund Gross 15,44% -1,76% 32,02% -0,40% 3,05% -9,22% 15,12% 19,47% 25,68% 18,04% 13,98%
Difference 0,17% 0,15% 0,24% 0,18% 0,19% 0,16% 0,09% 0,19% 0,09% 0,16% 0,22%
Index
MSCI Europe Health Care 35/20 Capped Index
15,27% -1,90% 31,77% -0,58% 2,86% -9,38% 15,03% 19,28% 25,59% 17,88% 13,76%

Performance Gross and Net of All Fees.

Capital Risk: Investing involves risk including the risk of loss of capital.

Past performance is not a guarantee of future results.

Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.

Calendar year inception performance returns will be partial for the year where the inception date for either the Fund in question or the historic performance-linked Fund (whichever is the earliest) falls within that period.


Deviation & Tracking Error as of 30 Sep 2021

Deviation & Tracking Error as of 30 Sep 2021

Standard Deviation Tracking Error
13,07% 0,15%
Standard Deviation 13,07%
Tracking Error 0,15%

This calculation is based on the past 3 years performance information.


Top Holdings

Top Holdings
Fund Top Holdingsas of 15 Oct 2021

Fund Top Holdings as of 15 Oct 2021

Security Name Weight
Roche Holding Ltd 17,27%
AstraZeneca PLC 11,80%
Novartis AG 11,65%
Novo Nordisk A/S Class B 10,87%
Sanofi 6,94%
GlaxoSmithKline plc 6,10%
Lonza Group AG 3,66%
Bayer AG 3,44%
Koninklijke Philips N.V. 2,56%
Alcon AG 2,47%
Download All Holdings: Download Daily Holdings

Industry Allocation

Industry Allocation
Fund Industry Allocationas of 15 Oct 2021

Fund Industry Allocation as of 15 Oct 2021

Sector Weight
Pharmaceuticals 73,35%
Health Care Equipment & Supplies 14,21%
Life Sciences Tools & Services 6,42%
Biotechnology 3,14%
Health Care Providers & Services 2,87%

Geographical Weights

Geographical Weights

Fund Footnote

Characteristics, holdings and sectors shown are as of the date indicated and are subject to change. This information should not be considered a recommendation to invest in a particular sector or to buy or sell any security shown. It is not known whether the sectors or securities shown will be profitable in the future. The holdings are taken from the accounting records of SSGA which may differ from the official books and records of the custodian.

Performance Gross and Net of All Fees.

Capital Risk: Investing involves risk including the risk of loss of capital.

Past performance is not a guarantee of future results.

Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.

First net asset value taken into account corresponds to the first end of month following complete investment of the portfolio in agreement with the policy of management. Historical performance is not necessarily indicative of actual future investment performance.

The financial products referred to herein are not sponsored, endorsed, or promoted by MSCI and MSCI bears no liability with respect to any such financial products or any index on which such financial products are based. The Prospectus contains a more detailed description of the limited relationship MSCI has with SSGA and any related financial products.

Previous to 1 December 2020, this Fund's Benchmark was the MSCI Europe Health Care Index.

© 2021 Morningstar, Inc. All rights reserved. The information contained herein; (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. State Street does not review the Morningstar data.